Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-24 @ 8:02 PM
NCT ID:
NCT05072704
Eligibility Criteria:
Inclusion Criteria:
* 18 years and older,
* Undergoing outpatient primary total hip arthroplasty under general anesthesia with laryngeal mask,
* Consent for participation,
* Affiliation to a social security system
Exclusion Criteria:
* Heart rate \< 60 bpm
* Chronic pain syndrome requiring preoperative morphine use (class 3)
* Contraindication for: paracetamol, ketoprofen, nefopam, oxycodone, propofol, ketamine, cisatracurium, sufentanyl, ropivacaine.
* Contraindication for dexmedetomidine: hypersensitivity to the active substance or to any of the excipients, advanced cardiac block (grade 2 or 3) unless paced ; uncontrolled hypotension ; acute cerebrovascular conditions
* Contraindication to laryngeal mask : old insulin-dependent diabetes, gastro-oesophageal reflux, morbid obesity (defined by BMI \> 35)
* Pregnant or breastfeeding women
* Women of child bearing potential without contraception (any contraceptive method used regularly and appropriately with a low failure rate: \<1% per year),
* A mental or linguistic inability to understand the study,
* Patient under protection of the adults (guardianship, curators or safeguard of justice),
* Patient included or planning to be included in another clinical trial relating to medications
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05072704
Study Brief:
Protocol Section:
NCT05072704